Antibiotic | Resistance rates | Resistance rates | Trend between ECO·SENS and ECO·SENS II | E. coliresistance data in the Austria resistance report 2008 for the ambulatory sector, n (%) |
---|---|---|---|---|
ECO·SENS | ECO·SENS II | |||
(N = 126), n (%) | (N = 146), n (%) | |||
Mecillinam | 2 (1.6) | 0 (0.0) | ↘ | 4,361 (12.2) |
Ampicillin | 22 (17.5) | 42 (28.8) | ↗ | 8,992 (39.8) |
Amoxicillin/clavulanic acid | 3 (2.4) | 13 (8.9) | ↗ | 8,985 (5.8) |
Trimethoprim | 12 (9.5) | 23 (15.8) | ↗ | - |
Sulphamethoxazole | 32 (25.4) | 31 (21.3) | ↘ | - |
Trimethoprim/Sulphamethoxazole | 12 (9.5) | 21 (14.4) | ↗ | 8,992 (24.6) |
Nalidixic acid | 3 (2.4) | 14 (9.6) | ↗ | - |
Nitrofurantoin | 1 (0.8) | 1 (0.7) | ↘ | 8,789 (2.2) |
Ciprofloxacin | 0 (0.0) | 6 (4.1) | ↗ | 8,992 (15.7) |
Gentamicin | 1 (0.8) | 2 (1.4) | ↗ | 8,990 (4.7) |
Fosfomycin trometamol | 0 (0) | 1 (0.7) | ↗ | 5,489 (1.5) |
Cefadroxil | 1 (0.8) | 6 (4.1) | 9,088 (8.5) | |
Cefotaxime | Not tested | 4 (2.7) | - | |
Ceftazidime | Not tested | 4 (2.7) | - |